137
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions

, , , , &
Pages 537-543 | Received 24 Jan 2017, Accepted 14 May 2017, Published online: 08 Jun 2017

References

  • Bai Y, Wang W, Sun G, Zhang M, Dong J. 2016. Curcumin inhibits angiogenesis by up-regulation of microRNA-1275 and microRNA-1246: a promising therapy for treatment of corneal neovascularization. Cell Prolif. 49:751–762.
  • Chen X, Lu P, Wang D-D, Yang S-J, Wu Y, Shen H-Y, Zhong S-L, Zhao J-H, Tang J-H. 2016. The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues. Gene. 595:221–226.
  • Chudzik B, Tracz IB, Czernel G, Fiołka MJ, Borsuk G, Gagoś M. 2013. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans. Eur J Pharm Sci. 49:850–857.
  • Colangelo V, François S, Soldà G, Picco R, Roma F, Ginelli E, Meneveri R. 2014. Next-generation sequencing analysis of miRNA expression in control and FSHD myogenesis. PLoS One. 9:e108411.
  • Collares CVA, Evangelista AF, Xavier DJ, Rassi DM, Arns T, Foss-Freitas MC, Foss MC, Puthier D, Sakamoto-Hojo ET, Passos GA, et al. 2013. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes. 6:491.
  • Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R. 2016. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PLoS One. 11:e0150154.
  • Dweep H, Sticht C, Kharkar A, Pandey P, Gretz N. 2013. Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model. PLoS One. 8:e53780.
  • Gagoś M, Czernel G, Kamiński D, Kostro K. 2011. Spectroscopic studies of amphotericin B-Cu2+ complexes. Biometals. 24:915–922.
  • Ge Y-Z, Xu L-W, Xu Z, Wu R, Xin H, Zhu M, Lu T-Z, Geng L-G, Liu H, Zhou C-C, et al. 2015. Expression profiles and clinical significance of microRNAs in papillary renal cell carcinoma: a STROBE-compliant observational study. Medicine (Baltimore). 94:e767.
  • Gola J, Strzałka-Mrozik B, Kruszniewska-Rajs C, Janiszewski A, Skowronek B, Gagoś M, Czernel G, Mazurek U. 2017. A new form of amphotericin B - the complex with copper (II) ions-downregulates sTNFR1 shedding and changes the activity of genes involved in TNF-induced pathways: AmB-Cu2+ downregulates sTNFR1 shedding and changes the activity of genes involved in TNF-induced pathways. Pharmacol Rep. 69:22–28.
  • Gola J, Skubis A, Sikora B, Kruszniewska-Rajs C, Adamska J, Mazurek U, Strzałka-Mrozik B, Czernel G, Gagoś M. 2015. Expression profiles of genes related to melatonin and oxidative stress in human renal proximal tubule cells treated with antibiotic amphotericin B and its modified forms. Turk J Biol. 39:856–864.
  • Hamam R, Ali AM, Alsaleh KA, Kassem M, Alfayez M, Aldahmash A, Alajez NM. 2016. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. Sci Rep. 6:25997.
  • He X, Liu Z, Peng Y, Yu C. 2016. MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-b pathway. Biochem Biophys Res Commun. 469:1041–1048.
  • Hsu JB-K, Chiu C-M, Hsu S-D, Huang W-Y, Chien C-H, Lee T-Y, Huang H-D. 2011. miRTar: an integrated system for identifying miRNA-target interactions in human. BMC Bioinformat. 12:300.
  • Jennings P, Limonciel A, Felice L, Leonard MO. 2012. An overview of transcriptional regulation in response to toxicological insult. Arch Toxicol. 87:49–72.
  • Jung SM, Lee J-H, Park J, Oh YS, Lee SK, Park JS, Lee YS, Kim JH, Lee JY, Bae Y-S, et al. 2013. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun. 4:2562.
  • Kanki M, Moriguchi A, Sasaki D, Mitori H, Yamada A, Unami A, Miyamae Y. 2014. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats. Toxicology. 324:158–168.
  • Kim J, Padanilam BJ. 2013. Renal nerves drive interstitial fibrogenesis in obstructive nephropathy. J Am Soc Nephrol. 24:229–242.
  • Koenig EM, Fisher C, Bernard H, Wolenski FS, Gerrein J, Carsillo M, Gallacher M, Tse A, Peters R, Smith A, et al. 2016. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity. BMC Genom. 17:649.
  • Lanternier F, Cypowyj S, Picard C, Bustamante J, Lortholary O, Casanova JL, Puel A. 2013. Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr. 25:736–747.
  • Lu Y, Qin B, Hu H, Zhang J, Wang Y, Wang Q, Wang S. 2016. Integrative microRNA-gene expression network analysis in genetic hypercalciuric stone-forming rat kidney. Peer J. 4:e1884.
  • Ludwig N, Werner TV, Backes C, Trampert P, Gessler M, Keller A, Lenhof H-P, Graf N, Meese E. 2016. Combining miRNA and mRNA expression profiles in wilms tumor subtypes. Int J Mol Sci. 17:475.
  • Lukamowicz-Rajska M, Mittmann C, Prummer M, Zhong Q, Bedke J, Hennenlotter J, Stenzl A, Mischo A, Bihr S, Schmidinger M. 2016. MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. Oncotarget. 7:78433–78447.
  • Marrone AK, Stolz DB, Bastacky SI, Kostka D, Bodnar AJ, Ho J. 2014. MicroRNA-17 ∼ 92 is required for nephrogenesis and renal function. J Am Soc Nephrol. 25:1440–1452.
  • Mi H, Muruganujan A, Casagrande JT, Thomas PD. 2013. Large-scale gene function analysis with the PANTHER classification system. Nat Protocols. 8:1551–1566.
  • Motta V, Angelici L, Nordio F, Bollati V, Fossati S, Frascati F, Tinaglia V, Bertazzi PA, Battaglia C, Baccarelli AA, et al. 2013. Integrative analysis of miRNA and inflammatory gene expression after acute particulate matter exposure. Toxicol Sci. 132:307–316.
  • Pavkovic M, Robinson-Cohen C, Chua AS, Nicoara O, Cárdenas-González M, Bijol V, Ramachandran K, Hampson L, Pirmohamed M, Antoine DJ, et al. 2016. Detection of drug-induced acute kidney injury in humans using urinary KIM-1, miR-21, -200c, and -423. Toxicol Sci. 152:205–213.
  • Perez-Carbonell L, Sinicrope FA, Alberts SR, Oberg AL, Balaguer F, Castells A, Boland CR, Goel A. 2015. MiR-320e is a novel prognostic biomarker in colorectal cancer. Br J Cancer. 113:83–90.
  • Pulverer W, Noehammer C, Vierlinger K, Weinhaeusel A. [Internet]; 2012. Principles and application of microarray technology in thyroid cancer research. In: Fahey TJ, editor. Updates in the understanding and management of thyroid cancer. Rijeka, Croatia: InTech. Available from: http://www.intechopen.com/books/updates-in-the-understanding-and-management-of-thyroidcancer/principles-and-application-of-microarray-technology-in-thyroid-cancer-research
  • Rivoli L, Vliegenthart AD, de Potter CM, van Bragt JJ, Tzoumas N, Gallacher P, Farrah TE, Dhaun N, Dear JW. 2016. The effect of renal dysfunction and haemodialysis on circulating liver specific miR-122. Br J Clin Pharmacol. 83:584–592.
  • Sayagués JM, Corchete LA, Gutiérrez ML, Sarasquete ME, Del Mar Abad M, Bengoechea O, Fermiñán E, Anduaga MF, Del Carmen S, Iglesias M, et al. 2016. Genomic characterization of liver metastases from colorectal cancer patients. Oncotarget. 7:72908–72922.
  • Shadkchan Y, Keisari Y, Segal E. 2004. Cytokines in mice treated with amphotericin B-intralipid. Med Mycol. 42:123–128.
  • Sun K-Y, Peng T, Chen Z, Huang J, Zhou X-H. 2016. MicroRNA-1275 suppresses cell growth, and retards G1/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5. J Cell Commun Signal. 10:305–314.
  • Szeto C-C, Ching-Ha KB, Ka-Bik L, Mac-Moune LF, Cheung-Lung CP, Gang W, Kai-Ming C, Kam-Tao LP. 2012. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis Mark. 33:137–144.
  • Tan G, Wu L, Tan J, Zhang B, Tai W. C-s, Xiong S, Chen W, Yang J, Li H. 2016. MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway. Sci Rep. 6:22328.
  • Tang Q, Zhong H, Xie F, Xie J, Chen H, Yao G. 2014. Expression of miR-106b-25 induced by salvianolic acid B inhibits epithelial-to-mesenchymal transition in HK-2 cells. Eur J Pharmacol. 741:97–103.
  • Turcatel G, Rubin N, El-Hashash A, Warburton D. 2012. MIR-99a and MIR-99b Modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells . PLoS One. 7:e31032.
  • Wang W, Shi Q, Mattes WB, Mendrick DL, Yang X. 2015. Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validation. Biomark Med. 9:1177–1188.
  • Yang Y-L, Ju H-Z, Liu S-F, Lee T-C, Shih Y-W, Chuang L-Y, Guh J-Y, Yang Y-Y, Liao T-N, Hung T-J, et al. 2011. BMP-2 suppresses renal interstitial fibrosis by regulating epithelial-mesenchymal transition. J Cell Biochem. 112:2558–2565.
  • Yuan J, Benway CJ, Bagley J, Iacomini J. 2015. MicroRNA-494 promotes cyclosporine-induced nephrotoxicity and epithelial to mesenchymal transition by inhibiting PTEN. Am J Transplant. 15:1682–1691.
  • Zhu X, Zhang C, Fan Q, Liu X, Yang G, Jiang Y, Wang L. 2016a. Inhibiting microRNA-503 and microRNA-181d with losartan ameliorates diabetic nephropathy in KKAy mice. Med Sci Monitor. 22:3902–3909.
  • Zhu HY, Bai WD, Li J, Tao K, Wang HT, Yang XK, Liu JQ, Wang YC, He T, Xie ST, Hu DH. 2016b. Peroxisome proliferator-activated receptor-γ agonist troglitazone suppresses transforming growth factor-β1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro. Am J Transl Res. 8:3460–3470.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.